These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 21062201)

  • 21. Sex differences among obstetrician-gynecologists: a review of survey studies.
    Farrow VA; Anderson B; Chescheir NC; Schulkin J
    Obstet Gynecol Surv; 2013 Mar; 68(3):235-53. PubMed ID: 23945840
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The medical management of menopause: a four-country comparison care in urban areas.
    Sievert LL; Saliba M; Reher D; Sahel A; Hoyer D; Deeb M; Obermeyer CM
    Maturitas; 2008 Jan; 59(1):7-21. PubMed ID: 18178044
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Patients' and clinicians' attitudes after the Women's Health Initiative study.
    Blümel JE; Castelo-Branco C; Chedraui PA; Binfa L; Dowlani B; Gómez MS; Sarrá S
    Menopause; 2004; 11(1):57-61. PubMed ID: 14716183
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Management of female sexual problems: perceived barriers, practice patterns, and confidence among primary care physicians and gynecologists.
    Abdolrasulnia M; Shewchuk RM; Roepke N; Granstaff US; Dean J; Foster JA; Goldstein AT; Casebeer L
    J Sex Med; 2010 Jul; 7(7):2499-508. PubMed ID: 20524976
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Menopausal symptom management and prevention counseling after the Women's Health Initiative among women seen in an internal medicine practice.
    Schonberg MA; Wee CC
    J Womens Health (Larchmt); 2005; 14(6):507-14. PubMed ID: 16115005
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of the WHI study on the attitude of Israeli gynecologists to hormonal therapy during menopause.
    Kaplan B; Yogev Y; Orvieto R; Hirsch M; Fisher M; Rabinerson D
    Clin Exp Obstet Gynecol; 2004; 31(4):267-8. PubMed ID: 15672962
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evolving practice patterns and attitudes toward hormone therapy of obstetrician-gynecologists.
    Power ML; Schulkin J; Rossouw JE
    Menopause; 2007; 14(1):20-8. PubMed ID: 17019376
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Opioid Prescribing Patterns by Obstetrics and Gynecology Residents in the United States.
    Baruch AD; Morgan DM; Dalton VK; Swenson C
    Subst Use Misuse; 2018 Jan; 53(1):70-76. PubMed ID: 28862884
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The relevance of the Women's Health Initiative results on combined hormone replacement therapy in clinical practice.
    Lemay A
    J Obstet Gynaecol Can; 2002 Sep; 24(9):711-5. PubMed ID: 12360366
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Changes of menopausal hormone therapy use pattern since 2000: results of the Berlin Spandau Longitudinal Health Study.
    Du Y; Scheidt-Nave C; Schaffrath Rosario A; Ellert U; Dören M; Knopf H
    Climacteric; 2009 Aug; 12(4):329-40. PubMed ID: 19437194
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Knowledge, attitudes, and reported practices among obstetrician-gynecologists in the USA regarding antibiotic prescribing for upper respiratory tract infections.
    Chamany S; Schulkin J; Rose CE; Riley LE; Besser RE
    Infect Dis Obstet Gynecol; 2005 Mar; 13(1):17-24. PubMed ID: 16040323
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Issues to debate on the Women's Health Initiative (WHI) study. Hormone replacement therapy: an epidemiological dilemma?
    Machens K; Schmidt-Gollwitzer K
    Hum Reprod; 2003 Oct; 18(10):1992-9. PubMed ID: 14507812
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Female OB/GYNs speak out about health practices.
    AWHONN Lifelines; 2004; 8(1):14-8. PubMed ID: 15031881
    [No Abstract]   [Full Text] [Related]  

  • 34. Obstetrician-gynecologist perceptions and utilization of prescription drug monitoring programs: A survey study.
    Goodin A; Bae J; Delcher C; Brown J; Roussos-Ross D
    Medicine (Baltimore); 2021 Jan; 100(1):e24268. PubMed ID: 33429837
    [TBL] [Abstract][Full Text] [Related]  

  • 35. What factors account for hormone replacement therapy prescribing frequency?
    Newton KM; LaCroix AZ; Buist DS; Anderson LA; Delaney K
    Maturitas; 2001 Jul; 39(1):1-10. PubMed ID: 11451615
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Provider management of menopause after the findings of the Women's Health Initiative.
    Rolnick SJ; Jackson J; Kopher R; Defor TA
    Menopause; 2007; 14(3 Pt 1):441-9. PubMed ID: 17318028
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recent epidemiological evidence relevant to the clinical management of the menopause.
    Shapiro S
    Climacteric; 2007 Oct; 10 Suppl 2():2-15. PubMed ID: 17882666
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Trends in office-based care for reproductive-aged women according to physician specialty: a ten-year study.
    Petterson SM; Bazemore AW; Phillips RL; Rayburn WF
    J Womens Health (Larchmt); 2014 Dec; 23(12):1021-6. PubMed ID: 25396270
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The drug industry and medical practice--the case of menopausal hormone therapy in Estonia.
    Hemminki E; Karttunen T; Hovi SL; Karro H
    Soc Sci Med; 2004 Jan; 58(1):89-97. PubMed ID: 14572923
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A decade of postmenopausal hormone therapy prescribing in the United States: long-term effects of the Women's Health Initiative.
    Steinkellner AR; Denison SE; Eldridge SL; Lenzi LL; Chen W; Bowlin SJ
    Menopause; 2012 Jun; 19(6):616-21. PubMed ID: 22648302
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.